CurveBeam AI Ltd. engages in the research, design, and manufacture of cone beam computed tomography imaging systems. The company is headquartered in Hatfield, Pennsylvania. The company went IPO on 2023-08-23. Its products include HiRise, LineUp, PedCAT Premium, pedCAT, InReach, OssView, CubeVue Software, Autometrics, 3D Measurement Tools and Cloud. HiRise is a bilateral, weight-bearing CT imaging of the entire lower extremities including hips/pelvis and distal upper extremities. LineUP is a bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities. InReach is a point-of-care extremity CT imaging for the upper extremities and the non-weight bearing lower extremities. InReach HR-pQCT is a high-resolution peripheral quantitative CT (HR-pQCT) imaging designed for the point-of-care. OssView is a bone fragility software that analyzes HR-pQCT images at the distal radius to measure the bone microarchitecture.
The current price of CRVAF is $0.054, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Curvebeam AI Ltd?
Curvebeam AI Ltd belongs to Health Care industry and the sector is Health Care
What is Curvebeam AI Ltd market cap?
Curvebeam AI Ltd's current market cap is $25.7M
Is Curvebeam AI Ltd a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Curvebeam AI Ltd, including 0 strong buy, 0 buy, 3 hold, 3 sell, and 0 strong sell